Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus

Cancer

Volumn 104, Issue 4, 2005, Pages 794-801

  Hata, Masaharu ^a,b   Tokuuye, Koichi ^a   Sugahara, Shinji ^a   Kagei, Kenji ^a   Igaki, Hiroshi ^a   Hashimoto, Takayuki ^a   Ohara, Kiyoshi ^a   Matsuzaki, Yasushi ^a   Tanaka, Naomi ^a   Akine, Yasuyuki ^a  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Hepatocellular carcinoma; Portal vein tumor thrombus; Proton beam therapy; Radiation therapy

Indexed keywords

ACUTE TOXICITY; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BEAM THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DERMATITIS; DIARRHEA; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER FAILURE; MALE; METASTASIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROTON RADIATION; RADIATION INJURY; SCORING SYSTEM; TELANGIECTASIA; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR THROMBUS; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; PORTAL VEIN; PROTONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 23444450016     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21237     Document Type: Article

References (45)

1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271-285.
2. Cook GC. Hepatocellular carcinoma: One of the world's most common malignancies. Q J Med. 1985;57:705-708.
3. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-1917.
4. Yu AS, Keeffe EB. Management of hepatocellular carcinoma. Rev Gastroenterol Disord. 2003;3:8-24.
5. Pawarode A, Voravud N, Sriuranpong V, et al. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol. 1998;21: 386-391.
6. Lee HS, Kim JS, Choi IJ, et al. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer. 1997;79:2087-2094.
7. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918-928.
8. Allison DJ, Jordan H, Hennessy O. Therapeutic embolisation of the hepatic artery: a review of 75 procedures. Lancet. 1985;1:595-599.
9. Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolisation in 120 patients with unresectable hepatoma. Radiology. 1983;148:397-401.
10. Ando E, Tanaka M, Yamashita F, et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus. Analysis of 48 cases. Cancer. 2002;95:588-595.
11. Itamoto T, Nakahara H, Tashiro H, et al. Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable of recurrent hepatocellular carcinoma with tumor thrombus of the portal vein. J Surg Oncol. 2002;80:143-148.
12. Doci R, Bignami P, Bozzetti F, et al. Intrahepatic chemotherapy for unresectable hepatocellular carcinoma. Cancer. 1988;61:1983-1987.
13. Lewin K, Millis RR. Human radiation hepatitis. A morphologic study with emphasis on the late changes. Arch Pathol. 1973;96:21-26.
14. Wharton JT, Delclos L, Gallager S, et al. Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med. 1973;117:73-80.
15. Matsuzaki Y, Osuga T, Saito Y, et al. A new, effective, and safe therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterology. 1994;106:1032-1041.
16. Tanaka N, Matsuzaki Y, Chuganji Y, et al. Proton irradiation for hepatocellular carcinoma. Lancet. 1992;340:1358.
17. Suit H, Urie M. Proton beams in radiation therapy. J Natl Cancer Inst. 1992;84:155-164.
18. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-649.
19. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours, 6th ed. New York: John Wiley & Sons, 2002.
20. Inada T, Hayakawa Y, Ohara K, et al. Treatment planning system for high energy proton beam. Nippon Acta Radiol. 1983;43:781-793.
21. Ando K, Koike S, Kawachi K, et al. Relative biological effectiveness of the therapeutic proton beam at NIRS and Tsukuba University. Nippon Acta Radiol. 1985;45:531-535.
22. Withers HR, Thames HD Jr., Peters LJ. A new isoeffect curve for change in dose per fraction. Radiother Oncol. 1983;1:187-191.
23. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47:207-214.
24. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
26. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan. Hepatology. 2000;32:1224-1229.
27. Horigome H, Nomura T, Nakao H, et al. Treatment of solitary small hepatocellular carcinoma: consideration of hepatic functional reserve and mode or recurrence. Hepatogastroenterology. 2000;47:507-511.
28. Markovic S, Gadzijev E, Stabuc B, et al. Treatment options in western hepatocellular carcinoma: a prospective study of 224 patients. J Hepatol. 1998;29:650-659.
29. Ikai I, Yamaoka Y, Yamamoto Y, et al. Surgical intervention for patients with Stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg. 1998;227:433-439.
30. Del Gaudio M, Grazi GL, Principe A, et al. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis. Hepatogastroenterology. 2004;51:510-514.
31. Kumada K, Ozawa K, Okamoto R, et al. Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery. 1990;108:821-827.
32. Kaneko S, Urabe T, Kobayashi K. Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis. Oncology. 2002;62(Suppl 1):69-73.
33. Sakon M, Nagano H, Dono K, et al. Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer. 2002;94:435-442.
34. Ingold JA, Reed GB, Kaplan HS, et al. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med. 1965;93:200-208.
35. Lawrence TS, Robertson JM, Anscher MS, et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31:1237-1248.
36. Jirtle RL, Anscher MS, Alati T. Radiation sensitivity of the liver. Adv Radiat Biol. 1990;14:269-311.
37. Stillwagon GB, Order SE, Guse C, et al. One hundred ninety-four hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study. Int J Radiat Oncol Biol Phys. 1989;17:1223-1229.
38. Park HC, Seong J, Han KH, et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2002;54:150-155.
39. Uno T, Itami J, Shiina T, et al. Radiation therapy in patients with unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol. 1992;31(Suppl):S106-S110.
40. Lawrence TS, Ten Haken RK, Kessler ML, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys. 1992;23:781-788.
41. Dawson LA, Ten Hakken RK, Lawrence TS. Partial irradiation of the liver. Semin Radiat Oncol. 2001;11:240-246.
42. Yamada K, Izaki K, Sugimoto K, et al. Prospective trail of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:113-119.
43. Ishikura S, Ogino T, Furuse J, et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Clin Oncol. 2002;25:189-193.
44. Huang CJ, Lian SL, Chen SC, et al. External beam radiation therapy for inoperable hepatocellular carcinoma with portal vein thrombosis. Kaohsiung J Med Sci. 2001;17:610-614.
45. Tazawa J, Maeda M, Sakai Y, et al. Radiation therapy on combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement. J Gastroenterol Hepatol. 2001;16:660-665.